Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches.
暂无分享,去创建一个
[1] D. Mcmahon-Pratt,et al. Leishmania‐infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells , 1996, European journal of immunology.
[2] E. Fuchs,et al. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. , 1996, Immunity.
[3] N. Glaichenhaus,et al. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages. , 1996, Journal of immunology.
[4] Li-Fang Wang,et al. Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. , 1996, Journal of immunology.
[5] J. Bluestone,et al. CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.
[6] A. Sette,et al. Peptide analogs with different affinites for MHC alter the cytokine profile of T helper cells. , 1996, International immunology.
[7] N. Ganguly,et al. Macrophage‐T cell interaction in murine salmonellosis: selective down‐regulation of ICAM‐1 and B7 molecules in infected macrophages and its probable role in cell‐mediated immunity , 1996, European journal of immunology.
[8] P. Allen,et al. Endogenous altered peptide ligands can affect peripheral T cell responses , 1996, The Journal of experimental medicine.
[9] M. Sarzotti,et al. Induction of Protective CTL Responses in Newborn Mice by a Murine Retrovirus , 1996, Science.
[10] T. Mosmann,et al. The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.
[11] I. Müller,et al. Susceptibility to Leishmania major Infection in Interleukin-4-Deficient Mice , 1996, Science.
[12] L. Adorini,et al. Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)- microglobulin-deficient BALB/c mice , 1996, The Journal of experimental medicine.
[13] P. Allen,et al. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. , 1996, Annual review of immunology.
[14] J. Woodgett,et al. CD28 signal transduction pathways. A comparison of B7-1 and B7-2 regulation of the map kinases: ERK2 and Jun kinases. , 1996, Molecular immunology.
[15] P. Linsley,et al. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. , 1995, Journal of immunology.
[16] H. Griesser,et al. Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.
[17] J. Bluestone,et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.
[18] A. Woodard,et al. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells , 1995, The Journal of experimental medicine.
[19] M. Feldmann,et al. Critical role of CD28/B7 costimulation in the development of human Th2 cytokine-producing cells. , 1995, Blood.
[20] K. Murphy,et al. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model , 1995, The Journal of experimental medicine.
[21] V. Maino,et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations , 1995, The Journal of experimental medicine.
[22] J. West,et al. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. , 1995, Journal of immunology.
[23] A. Sette,et al. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[24] V. Kuchroo,et al. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. , 1995, Immunity.
[25] B. Smith,et al. CD4 and CD45 regulate qualitatively distinct patterns of calcium mobilization in individual CD4+ T cells , 1995, European journal of immunology.
[26] N. Ganguly,et al. Macrophage‐T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania‐infected macrophages and its implication in the suppression of cell‐mediated immunity , 1995, European journal of immunology.
[27] C Danieli,et al. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.
[28] C. Thompson,et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.
[29] J. Bluestone. New perspectives of C1328-137-mediated T cell costimulation , 1995 .
[30] R. Flavell,et al. Peptide and protein antigens require distinct antigen-presenting cell subsets for the priming of CD4+ T cells. , 1995, Journal of immunology.
[31] R. Steinman,et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing , 1995, Nature.
[32] J. Gribben,et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. , 1995, Immunity.
[33] M. Croft,et al. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. , 1995, Journal of immunology.
[34] P. Linsley,et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2 , 1995, The Journal of experimental medicine.
[35] A. Sette,et al. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. , 1995, Immunity.
[36] A. Sette,et al. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo , 1995, The Journal of experimental medicine.
[37] Laurie H Glimcher,et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.
[38] M. Peters. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1995 .
[39] D. Umetsu,et al. Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type , 1995, The Journal of experimental medicine.
[40] J. Bluestone,et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse , 1995, The Journal of experimental medicine.
[41] C. June,et al. CD28 activation promotes Th2 subset differentiation by human CD4+ cells , 1995, European journal of immunology.
[42] L. Samelson,et al. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists , 1995, Science.
[43] P. Linsley,et al. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. , 1995, Journal of immunology.
[44] A. Bendelac. Mouse NK1+ T cells. , 1995, Current opinion in immunology.
[45] Paul M. Allen,et al. Partial T cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy , 1994, Cell.
[46] K. Else,et al. Low‐level infection with Trichuris muris significantly affects the polarization of the CD4 response , 1994, European journal of immunology.
[47] P. Linsley,et al. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. , 1994, Journal of immunology.
[48] R. Steinman,et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro , 1994, The Journal of experimental medicine.
[49] M. Cooke,et al. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. , 1994, Journal of immunology.
[50] P. Linsley,et al. CTLA-4 can function as a negative regulator of T cell activation. , 1994, Immunity.
[51] P. Linsley,et al. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function , 1994, The Journal of experimental medicine.
[52] P. Linsley,et al. CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite , 1994, The Journal of experimental medicine.
[53] A. Sette,et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1994, Nature.
[54] Sarah Rowland-Jones,et al. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants , 1994, Nature.
[55] A. Abbas,et al. Costimulator dependence of lymphokine secretion by naive and activated CD4+ T lymphocytes from TCR transgenic mice. , 1994, Journal of immunology.
[56] J. West,et al. Are primed CD4+ T lymphocytes different from unprimed cells? , 1994, European journal of immunology.
[57] N. Nabavi,et al. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. , 1994, Immunity.
[58] R. Schwartz,et al. A subset of CD4+ thymocytes selected by MHC class I molecules. , 1994, Science.
[59] P. Linsley,et al. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production , 1994, The Journal of experimental medicine.
[60] S. Romagnani. Lymphokine production by human T cells in disease states. , 1994, Annual review of immunology.
[61] W. Paul,et al. Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, Annual review of immunology.
[62] R. Flavell,et al. The relationship of IL-4- and IFNγ-producing T cells studied by lineage ablation of IL-4-producing cells , 1993, Cell.
[63] A. Sher,et al. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[64] Kenneth M. Murphy,et al. Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from αβ TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ-dependent , 1993 .
[65] F. Finkelman,et al. Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-gamma in CD4+ T cells. , 1993, International immunology.
[66] K P Lee,et al. Differential T cell costimulatory requirements in CD28-deficient mice. , 1993, Science.
[67] P. Scott. Selective differentiation of CD4+ T helper cell subsets. , 1993, Current opinion in immunology.
[68] A. Sher,et al. Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha. , 1993, Journal of immunology.
[69] M. Croft,et al. T-cell memory: new perspectives. , 1993, Immunology today.
[70] Martin Bachmann,et al. Disruption of the murine IL-4 gene blocks Th2 cytokine responses , 1993, Nature.
[71] W. Paul,et al. Anti-IL-4 diminishes in vivo priming for antigen-specific IL-4 production by T cells. , 1993, Journal of immunology.
[72] P. Linsley,et al. The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.
[73] P. Linsley,et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 , 1992, Cell.
[74] P. Linsley,et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes , 1992, The Journal of experimental medicine.
[75] Giorgio,et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells , 1992, The Journal of experimental medicine.
[76] W. Paul,et al. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice , 1992, The Journal of experimental medicine.
[77] D. Katz,et al. Antigen concentration determines helper T cell subset participation in IgE antibody responses. , 1992, Cellular immunology.
[78] H. Bielefeldt-Ohmann,et al. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. , 1992, Science.
[79] C. Hsieh,et al. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[80] C. Heusser,et al. Bee venom phospholipase A2‐specific T cell clones from human allergic and non‐allergic individuals: cytokine patterns change in response to the antigen concentration , 1992, European journal of immunology.
[81] K. Bottomly,et al. Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell‐mediated responses in mice of distinct MHC genotype , 1992, European journal of immunology.
[82] M. Davis,et al. Molecular components of T-cell recognition. , 1992, Annual review of immunology.
[83] W. Paul,et al. Mouse splenic and bone marrow cell populations that express high-affinity Fc epsilon receptors and produce interleukin 4 are highly enriched in basophils. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[84] R. Locksley,et al. Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection. , 1991, Research in immunology.
[85] A. Weinberg,et al. IL-4 directs the development of Th2-like helper effectors. , 1990, Journal of immunology.
[86] F. Finkelman,et al. Anti-CD3 antibody induces rapid expression of cytokine genes in vivo. , 1990, Journal of immunology.
[87] W. Paul,et al. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4- producing cells , 1990, The Journal of experimental medicine.
[88] S. Carding,et al. MHC control of CD4+ T cell subset activation , 1989, The Journal of experimental medicine.
[89] B. Torbett,et al. A new murine CD4+ T cell subset with an unrestricted cytokine profile. , 1989, Journal of immunology.
[90] W. Paul,et al. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores , 1989, Nature.
[91] A. Woods,et al. Differential activation of cytokine genes in normal CD4‐bearing T cells is stimulus dependent , 1989, European journal of immunology.
[92] R. Stout,et al. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. , 1989, Journal of immunology.
[93] R. Locksley,et al. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets , 1989, The Journal of experimental medicine.
[94] E. Unanue,et al. Intracellular interference with antigen presentation. , 1988, Journal of immunology.
[95] J. Abrams,et al. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. , 1988, Journal of immunology.
[96] R. Coffman,et al. The Role of Helper T Cell Products in Mouse B Cell Differentiation and Isotype Regulation , 1988, Immunological reviews.
[97] T. Mosmann,et al. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. , 1987, Journal of immunology.
[98] A. Woods,et al. Cloned, Ia-restricted T cells that do not produce interleukin 4(IL 4)/B cell stimulatory factor 1(BSF-1) fail to help antigen-specific B cells. , 1987, Journal of immunology.
[99] R. Coffman,et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.
[100] B. Benacerraf,et al. T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo. , 1986, Journal of immunology.
[101] A. Woods,et al. Distinct functional phenotypes of cloned Ia-restricted helper T cells , 1985, The Journal of experimental medicine.
[102] F. Liew,et al. IMMUNE RESPONSE TO CHEMICALLY MODIFIED FLAGELLIN III. ENHANCED CELL-MEDIATED IMMUNITY DURING HIGH AND LOW ZONE ANTIBODY TOLERANCE TO FLAGELLIN , 1972 .